Best Practices for Natalizumab Utilization in the Treatment of Multiple Sclerosis

home / publications / supplement / a282_2010jun

Quantifying the Role of Natalizumab in Health and Economic Outcomes in Multiple Sclerosis

David W. Brandes, MS, MD, FAAN;Fadia T. Shaya, PhD, MPH;Michael W. Pill, PharmD

ArticleARTICLES

Recommendations for the Selection, Treatment, and Management of Patients Utilizing Natalizumab Therapy for Multiple Sclerosis

ArticleARTICLES

The Role of Natalizumab in the Treatment of Multiple Sclerosis

Patricia K. Coyle, MD

ArticleARTICLES

Participating Faculty

ArticleSupplements

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions